No trials match your search ""

• Magnetic Resonance Imaging of Breast Cancer

  Stanford is currently accepting patients for this trial.

• Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors

  Stanford is currently accepting patients for this trial.

• Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT

  Stanford is currently accepting patients for this trial.

• 68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer

  Stanford is currently accepting patients for this trial.

• Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma

  Stanford is currently accepting patients for this trial.

• A First-in-human Study Using BDC-1001 in Advanced HER2-Expressing Solid Tumors

  Stanford is currently accepting patients for this trial.

• Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

  Stanford is currently accepting patients for this trial.

• Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

  Stanford is currently accepting patients for this trial.

• Mental Health Disparities in Spanish Speaking Latina Breast Cancer Patients

  Stanford is currently accepting patients for this trial.

• Investigation of Novel Surgical Imaging for Tumor Excision

  Stanford is currently accepting patients for this trial.

• An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic

  Stanford is currently accepting patients for this trial.

• A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

  Stanford is currently accepting patients for this trial.

• A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)

  Stanford is currently accepting patients for this trial.

• Phase II Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma

  Stanford is currently accepting patients for this trial.

• Study of Infigratinib in Combination With Tamoxifen or With Fulvestrant and Palbociclib in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer

  Stanford is currently accepting patients for this trial.

• Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC

  Stanford is currently accepting patients for this trial.

• Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

  Stanford is currently accepting patients for this trial.

• A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• Previous
• 1
• 2
• Next

No trials match your search ""

No trials match your search ""

No trials match your search ""

No trials match your search ""

No trials match your search ""

• International Lymphatic Disease and Lymphedema Registry

  Stanford is currently accepting patients for this trial.

No trials match your search ""

• A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma

  Stanford is currently accepting patients for this trial.

• A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)

  Stanford is currently accepting patients for this trial.

• Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer

  Stanford is currently accepting patients for this trial.

• Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma

  Stanford is currently accepting patients for this trial.

• Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma

  Stanford is currently accepting patients for this trial.

• Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

  Stanford is currently accepting patients for this trial.

• Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma

  Stanford is currently accepting patients for this trial.

• Pembrolizumab Compared to Standard of Care Observation in Treating Patients With Completely Resected Stage I-III Merkel Cell Cancer, STAMP Study

  Stanford is currently accepting patients for this trial.

• A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma

  Stanford is currently accepting patients for this trial.

• Expanded Access for ABI-009 in Patients With Advanced PEComa and Patients With a Malignancy With Relevant Genetic Mutations or mTOR Pathway Activation

  Stanford is currently accepting patients for this trial.

• Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors

  Stanford is currently accepting patients for this trial.

• Phase 1 Study of SQ3370 in Patients With Advanced Solid Tumors

  Stanford is currently accepting patients for this trial.

• CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma

  Stanford is currently accepting patients for this trial.

• Study of DCC-3014 in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

  Stanford is currently accepting patients for this trial.

• Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

  Stanford is currently accepting patients for this trial.

• Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

  Stanford is currently accepting patients for this trial.

• Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

  Stanford is currently accepting patients for this trial.

• ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma

  Stanford is currently accepting patients for this trial.

• Detection of Immune Changes as a Result of Surgical Trauma in Human Subject

  Stanford is currently accepting patients for this trial.